At a glance
ClinicalIndex Comparison RecordN/ACompleted· 10 enrolled
Drug / intervention
Collection of clinical, psychometric and biometric dataother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Prospective Data Collection for SENSING-AI: A Precision Digital and Wearables Platform for the Early Diagnosis of Emotional and Physical Complications in Patients With Long COVID Through the Use of Artificial Intelligence
In Brief
An observational study evaluating Collection of clinical, psychometric and biometric data for Post-acute COVID-19 Syndrome. Completed, enrolled 10 participants across 2 sites.
Detailed Summary
The prospective study will focus on the collection of biometric and psychometric data from a limited population for 1 month with the aim of complementing the SENSING-AI retrospective cohort.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPost-acute COVID-19 Syndrome
CountriesSpain
Timeline
N/ACompletedFinished
20222023202420252026
Enrollment StartJan 2022
First PostedJan 2022
Primary CompletionFeb 2022
Study CompletionApr 2022
TodayJul 2026
First PostedJan 24, 2022
Enrollment StartJan 18, 2022
Primary CompletionFeb 12, 2022
Study CompletionApr 28, 2022
TodayJul 2, 2026
Enrollment to primary: 24 daysPosted 4.4 years ago
Interventions
Collection of clinical, psychometric and biometric dataother
Wearable devices and a mobile app will be used to collect real-time data for 4 weeks to detect physiological and psychological complications based on biometric and psychometric (patient-reported outcomes) information.